Aurum Resources (AUE:AU) has announced More high grade gold intercepts at BMT3 in Boundiali
Download the PDF here.
This post appeared first on investingnews.com
South Harz Potash Limited (SHP:AU) has announced SHP Secures 25km Copper-Gold Corridor in Sweden
Download the PDF here.
This post appeared first on investingnews.com
Metals Australia (MLS:AU) has announced High Copper Anomalies Show Deeper Potential at Warrego East
Download the PDF here.
This post appeared first on investingnews.com
/NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA/
Freegold Ventures Limited (TSX: FVL,OTC:FGOVF) (OTCQX: FGOVF) (the ‘Company’ or ‘Freegold Ventures’), is pleased to announce that it has entered into an agreement with Paradigm Capital Inc. (‘Paradigm’), pursuant to which Paradigm will act as lead agent and sole bookrunner on behalf of a syndicate of agents (together with Paradigm, the ‘Agents’) to be formed in connection with a proposed brokered ‘best efforts’ private placement financing (the ‘Offering’) for total gross proceeds of $30,000,100, consisting of 23,077,000 common shares of the Company (the ‘Common Shares’) at a price of $1.30 per Common Share (‘Issue Price’).
The Company will grant the Agents an option (the ‘Agents’ Option‘) to sell up to that number of additional Common Shares equal to 15% of the base Offering size, exercisable, by notice in writing to the Company, at any time not less than 48 hours prior to the Closing Date.
The net proceeds from the Offering will be used to complete a Pre-Feasibility Study for the Golden Summit Project, to support ongoing exploration, and for general corporate and working capital purposes. Management believes that these funds will further strengthen the Company’s ability to advance the Golden Summit Project as it moves the project through the pre-feasibility stage.
The Common Shares will be offered for sale pursuant to Part 5A of National Instrument 45-106 – Prospectus Exemptions, as amended by Coordinated Blanket Order 45-935 – Exemptions from Certain Conditions of the Listed Issuer Financing Exemption (the ‘Listed Issuer Financing Exemption‘), to purchasers resident in each of the provinces of Canada (other than Québec), and in other qualifying jurisdictions outside of Canada that are mutually agreed to by the Company and the Agents pursuant to relevant prospectus or registration exemptions in accordance with applicable laws. As the Offering is being completed pursuant to the Listed Issuer Financing Exemption, the Common Shares issued in the Offering will not be subject to a hold period in Canada pursuant to applicable Canadian securities laws.
There is an offering document related to this Offering that can be accessed under the Company’s profile at www.sedarplus.ca and on the Company’s website at www.freegoldventures.com. Prospective investors should read this offering document before making an investment decision.
The Offering is expected to close on or about January 6, 2026 (the ‘Closing Date‘) and will be subject to regulatory approvals and customary closing conditions, including listing of the Common Shares on the Toronto Stock Exchange.
The Agents will be entitled to, on the Closing Date, a cash commission equal to 5% of the gross proceeds of the Offering including on any exercise of the Agents’ Option.
The securities have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the ‘U.S. Securities Act‘), or any U.S. state securities laws, and may not be offered or sold in the United States without registration under the U.S. Securities Act and all applicable state securities laws or compliance with the requirements of an applicable exemption therefrom. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor may there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.
About Freegold Ventures Limited
Freegold Ventures is a TSX-listed company focused on exploration in Alaska.
Forward-looking Information Cautionary Statement
This press release contains statements that constitute ‘forward-looking information’ (collectively, ‘forward-looking statements’) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this press release. Any statement that discusses predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as ‘expects’, or ‘does not expect’, ‘is expected’, ‘anticipates’ or ‘does not anticipate’, ‘plans’, ‘budget’, ‘scheduled’, ‘forecasts’, ‘estimates’, ‘believes’ or ‘intends’ or variations of such words and phrases or stating that certain actions, events or results ‘may’ or ‘could’, ‘would’, ‘might’ or ‘will’ be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. Forward-looking statements contained in this press release, include, without limitation, statements regarding the receipt of TSX final approval for the Offering and the use of proceeds from the Offering. In making the forward-looking statements contained in this press release, the Company has made certain assumptions. Although the Company believes that the expectations reflected in forward-looking statements are reasonable, it can give no assurance that the expectations of any forward-looking statements will prove to be correct. Known and unknown risks, uncertainties, and other factors may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: availability of financing; delay or failure to receive required permits or regulatory approvals; and general business, economic, competitive, political and social uncertainties. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this press release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise. See Freegold’s Annual Information Form for the year ended December 31, 2024, filed under Freegold’s profile at www.sedarplus.ca, for a detailed discussion of the risk factors associated with Freegold’s operation.
SOURCE Freegold Ventures Limited
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/December2025/18/c0220.html
News Provided by Canada Newswire via QuoteMedia
This post appeared first on investingnews.com
Alexandria Ocasio-Cortez is incorporating Gen Z messaging and viral jabs at Vice President J.D. Vance into her playbook as she builds momentum for a 2028 presidential run, a Republican political strategist has claimed.
The strategist’s comments came after the New York Democrat used meme-style language and mocked Vance on Dec. 17 over a poll and declared she would ‘stomp him’ if the matchup became real.
‘It is a case of the squeaky wheel gets the grease, so it wouldn’t be surprising that she will run a vibes-based campaign,’ Libby Krieger of the Communications Counsel told Fox News Digital.
‘This is because a lot of her substance is soundbites or progressive policies,’ Krieger added.
Ocasio-Cortez sparked the first round of attention Wednesday by reposting the Verasight poll on X.
The poll showed her narrowly ahead of Vance, 51% to 49%, in a hypothetical 2028 matchup. Her first response was ‘Bloop!’
Ocasio-Cortez’s communication style morphed into a second message later Wednesday declaring she would ‘stomp him’ if the 2028 race became real.
When asked by a reporter if she thought she could defeat the 41-year-old, she replied: ‘Listen, these polls, like three years out, are, you know, they are what they are. But let the record show: I would stomp him. I would stomp him!’
The two moments highlighted what Krieger says will evolve into a youth-oriented, ‘vibes’-driven campaign targeted toward young voters.
‘AOC is trying to lean into the Gen Z language and connect with younger voters,’ she said.
‘She is setting up a campaign that would be based more on vibes than on her policy platform.’
Krieger compared the approach to Kamala Harris’ attempt to embrace ‘brat’ culture during the last cycle.
‘This almost seems reminiscent of Kamala’s use of ‘brat’ and her version of that,’ she said.
‘AOC would probably do a little bit better than Kamala in running a campaign based on vibes because she’s younger,’ she explained.
‘But she’ll still have to talk some policy, as not every voter will be content with voting on vibes – and when she does talk policy, they’ll all see how radical she really is.’
‘AOC is not a great candidate because the policies that she has come to be known for are extremely progressive,’ Krieger added.
‘If she were to make it to a general election she would have to center herself a little bit more to the middle, but that’d be hard given the reputation she’s made for herself.’
By contrast, Krieger said Vance holds an advantage with voters who prioritize depth and policy grounding.
‘J.D. Vance has more substance than AOC and I think Americans would see that,’ she said. ‘Vance knows his stuff on nearly every issue and is extremely articulate, and he’s also young.’
She added that both Ocasio-Cortez and Vance tap into newer strains of populism, including a willingness to appear casual or self-aware online.
‘Decorum can sometimes be perceived as elitist or very establishment,’ she said. ‘But Vance has the advantage of not just being a squeaky wheel like AOC while still being young enough to come across as relatable.’
Fox News Digital has reached out to Alexandria Ocasio-Cortez and J.D. Vance for comment.
This post appeared first on FOX NEWS
The long-debated issue of US cannabis rescheduling is finally back in the spotlight.
On Thursday (December 18), President Donald Trump signed an executive order to expedite the process of moving cannabis from Schedule I to Schedule III under the Controlled Substances Act. Market watchers are now assessing what such a shift could mean for the industry, from taxation and access to broader investment potential.
What do industry experts think about cannabis rescheduling?
Sasha Nutgent, vice president of cannabis retail, Housing Works Cannabis
As it stands today with the current classification, retailers are not incentivized to operate legally. Reclassification would change that for thousands of businesses, especially those owned by folks from communities most impacted by the war on drugs.
Anthony Coniglio, CEO of NewLake Capital Partners (OTCQX:NLCP)
We welcome President Trump’s directive to the Department of Justice to finalize the rescheduling of cannabis from Schedule I to Schedule III. This represents a historic and long-overdue alignment of federal policy with scientific evidence, medical practice and the regulatory reality already functioning across most US states.
Now, follow through is critical. We urge the DOJ and DEA to move swiftly to issue the Final Rule and complete the rescheduling process. Doing so would finally remove the punitive burden of Section 280E, allowing compliant, state-licensed operators to reinvest in growth, innovation and workforce development across the nearly half-million Americans employed in this industry. This is not about legalization — it’s about legitimacy. Responsible operators have long followed strict state-level compliance frameworks that prioritize safety, transparency and consumer protection. Rescheduling would rightfully distinguish these businesses from illicit markets and allow federal enforcement to focus where it truly belongs: on criminal cartels, not compliant small businesses. This announcement is a milestone, not a finish line. Congress must build on this momentum by passing the bipartisan SAFER Banking Act and advancing STATES 2.0 to create a durable national framework that strengthens safety, access and accountability for all stakeholders.
Harrison Bard, CEO and co-founder, Custom Cones USA and DaySavers
Rescheduling will further stack the odds against small operators, but this type of change is a long-overdue step toward treating cannabis like the legitimate medicine so many veterans already rely on. For years they’ve been forced to navigate stigma, inconsistent access and out-of-pocket costs just to manage pain, PTSD and other service-related conditions. A more rational federal framework won’t solve everything, but it moves us closer to the kind of recognition, research and support our veterans deserve. At DaySavers, we’ve tried to honor that community in our own small way through our ‘Cones for a Cause’ line, which sends a portion of proceeds directly to the Weed for Warriors Project. Veterans have carried the weight for the rest of us; it’s time our policies — and our industry — carry some of it back.
Chris Fontes, founder and CEO, High Spirits
While any incremental progress for normalizing cannabis is worth celebrating, Schedule III is not the savior the industry believes it to be. The requirements for legal participation in a Schedule III market are burdensome, and it’s unlikely that any significant portion of the industry will be able to properly participate.
Relief from 280e is exciting, but selling a Schedule III drug without drug approval, licensure, etc. is still quite illegal. Sadly, this will not be the win the industry wants it to be, and much more work is yet to be done. Further, let’s not forget we already have some version of cannabis that is completely descheduled, and we’re still fighting to keep it that way.
Therefore, we should be cautious to simultaneously celebrate marijuana moving to Schedule III while also ignoring — or in some cases, celebrating — the rescheduling of hemp products that are currently off the schedule all together.
Will cannabis rescheduling improve access to banking?
Sierra Elaina, CEO, Lehua Brands
Rescheduling cannabis would be a turning point for an industry that’s been operating under impossible conditions. Treating cannabis as a Schedule I drug has restricted banking, crushed margins through unfair tax rules and prolonged stigma that no longer reflects reality. This change could finally legitimize cannabis as a regulated business — one with access to banking, fair taxation and a path forward for operators who have been hanging on by a thread.
Terry Mendez, CEO, Safe Harbor Financial
President Trump’s rescheduling cannabis by executive order marks a significant shift in tone from Washington and a meaningful moment for an industry long stuck in legal limbo. Reclassifying cannabis as Schedule III would acknowledge its medical legitimacy and begin to correct a half-century of misguided federal policy.
That said, rescheduling is not reform. The core challenges around cannabis banking such as compliance burdens, cash dependency and regulatory uncertainty would remain unchanged. The industry would still fall under the Bank Secrecy Act, with all its reporting and monitoring obligations intact. This moment is likely to invite broader interest from financial institutions, but without structural reform or updated guidance, many will remain cautious. A true fix requires a coordinated federal framework that aligns financial policy with the realities of a US$38 billion state-legal industry. Any step forward is welcome, but incremental progress should not be mistaken for a comprehensive solution. The cannabis sector deserves financial clarity, not just legal signals.
Ryan Hunter, chief revenue officer, Spherex
Cannabis is still federally illegal — but even as a federally illegal substance — the move to Schedule III dramatically reduces the federal tax burden for operators. Under IRS code 280E, handling Schedule I or Schedule II substances eliminates the ability for operators to deduct standard operating expenses that most other businesses deduct from their federal taxes. As a result of 280E, cannabis operators’ effective tax rate may be as high as 80 percent.
Beyond this significant improvement, the implications are unclear, but we’re hopeful that this move will allow for cannabis operators to garner the same investment opportunities other industries will enjoy.
Joe Gerrity, CEO, Crescent Canna
If marijuana is reclassified to Schedule III, it immediately strengthens the regulated marijuana industry by eliminating 280E and recognizing legitimate medical uses — but the more important ripple effect is what it means for hemp. With hemp THC products set to be effectively banned next November without new legislation, a federal move to loosen restrictions on marijuana while simultaneously eliminating a thriving hemp market is completely illogical and contradictory. Reclassification increases the likelihood that Congress and the federal government will move toward a coherent framework that keeps hemp products legal but properly regulated.
Mark Lewis, president of Specialty Payments, Lüt
Make no mistake, rescheduling is just the beginning for those working in the cannabis industry. Until the SAFE Banking Act or 280E is passed, operators will still have to jump through challenging financial hoops to pay their staff, bills or garner investment. The moment is historic, but until cannabis businesses can operate fiscally with the same ease as any other business, more work needs to be done.
Payments still need to work in the reality of today, where the ongoing threat of card network shutdowns exists, not just the promise of future reform. While rescheduling may open doors over time, it does not remove the day-to-day financial friction that cannabis operators face right now.
Lüt is uniquely positioned to support the cannabis industry and help businesses grow safely, compliantly and confidently.
Adam Stettner, CEO, FundCanna
Rescheduling cannabis to Schedule III will deliver immediate, measurable impacts. Most notably, it eliminates Section 280E from the federal tax equation for licensed operators — a change that, for many, is the difference between treading water and turning a profit. It also unlocks long-blocked research pathways, enabling rigorous clinical studies, standardized formulations, and a new era of product innovation.
Additionally, it has catalyzed a broader shift across the industry pushing cannabis businesses to adopt more institutional practices around banking, compliance, financial reporting and governance.
What would rescheduling mean for medical cannabis?
Ryan Hunter, chief revenue officer, Spherex
The real win here is for medical cannabis. By moving cannabis to Schedule III, Cannabis will be treated similarly to ketamine, Tylenol + Codeine and anabolic steroids — all drugs that have been approved by the FDA for use with a doctor’s prescription. Not only will those in states without medical cannabis programs gain access, but as markets evolved to recreational programs, many remedies for patients have been left behind due to the dramatically larger demand for adult use products relative to medical products. At Schedule III, it’s much more practical for mainstream physicians to prescribe cannabis products.
Alex Gonzalez, president and co-founder, Calyx Containers
Whenever the White House moves forward with Schedule III, the federal government is effectively telling us that cannabis is medicine. And if it’s medicine, ‘good enough’ cannabis practices won’t cut it anymore. Whether rescheduling happens next month or next year, the direction is clear: cannabis is moving toward pharma-grade standards. For brands, that means tightening quality systems, investing in the ability to react or scale and preparing for a regulatory-ready supply chain. We’re seeing the smart operators on shoring infrastructure and we’re positioning our domestic production and business model on being ready to help operators turn this moment into a competitive advantage.
Mark Lewis, president of specialty payments, Lüt
Rescheduling is the single most important drug policy move in decades. The potential opportunities for medical and scientific research will significantly increase, while those living in states without an existing medical program will now have access to the powerful healing properties of the plant.
Ali Garawi, co-founder, CEO and CFO, Muha Meds
If Trump moves to reschedule cannabis, it would be a long-overdue acknowledgment that this plant never belonged in the most restrictive drug category. Cannabis has centuries of real-world use behind it for pain management, appetite and sleep, yet it has been trapped in a legal framework built on fear, stigma and misinformation. Federal prohibition hasn’t protected consumers — it has only created impossible hoops for legitimate businesses to jump through.
While cannabis should be entirely descheduled, rescheduling is an important move forward. It would create space for common-sense regulation, banking access, medical research and consumer protections that should have existed years ago. For consumers, that means safer products, better testing standards, more consistent access and pricing that reflects a functioning, regulated market rather than prohibition-era risk.
At a time when the country is facing an ongoing overdose and mental health crisis, continuing to treat cannabis as a threat is nonsensical. Rescheduling would not solve everything, but it would be a meaningful step toward replacing outdated ideology with education, safety and public health reality.
Josh Kesselman, publisher, High Times Magazine; founding force behind RAW Rolling Papers
I, among others in the industry, are very concerned that Trump’s news of rescheduling is a false flag!
Moving THC to Schedule III would allow big pharma to launch their synthetic THC pills available by prescription only at huge costs and subject current dispensaries to a whole new set of felonies under the FDCA (Food and Drug Cosmetic Act). These “new” federal crimes include selling a prescription drug without a license, dispensing a drug without a prescription, misbranding a drug, illegal distribution, conspiracy and more!
In fact, the penalties under Schedule III actually increase, not decrease, depending on what a federal prosecutor chooses to charge a seller or grower with.
Gennaro Luce, founder and CEO, CannaLnx, powered by EM2P2
Rescheduling is an important and overdue shift for patient-centric healthcare, but the move to Schedule III alone isn’t enough to make medical cannabis more accessible or affordable. Schedule III puts cannabis in the same drug class as certain types of Tylenol, but what does that mean for patients? We hope it means more will be able to access their medicine through insurance plans and traditional doctors.
But insurers still need verification, compliance and eligibility frameworks before they can treat medical cannabis like a real benefit. That part of the system is still missing from the national conversation — fortunately, it’s the medical-cannabis system piece we’ve already built and tested alongside physicians, patients, dispensaries, POS systems and insurers.
Gibran Washington, CEO, Ethos
Rescheduling cannabis from Schedule I to Schedule III is a long-overdue acknowledgment of what patients, providers and responsible operators have known for years: this plant has real therapeutic value, and the current federal posture has been holding progress back. Rescheduling won’t fix every challenge in front of us, but it finally moves us in the right direction opening clearer pathways for research, easing unnecessary barriers for patients and creating a more functional regulatory environment for operators who are doing this the right way.
At Ethos, our commitment has always been to education, science and access. This shift should be the beginning of broader reforms that address affordability, equity and the stigma that still shadows this industry. If done thoughtfully, rescheduling can be a catalyst for a more transparent, patient-centered and responsible cannabis ecosystem.
JP Doran, CEO, Crucial Innovations
We applaud the US government for undertaking the most significant reform in federal cannabis policy since the 1970s. While rescheduling stops short of full federal legalization, it meaningfully reduces research barriers, modernizes regulatory oversight and formally acknowledges the medical value of cannabis within federal policy.
Because this development comes from the world’s largest pharmaceutical market, its impact extends far beyond US borders. It is expected to catalyze international momentum, encouraging regulators in the UK, EU, South Africa and other emerging markets to revisit outdated frameworks, align with evolving scientific evidence and create clearer pathways for medical cannabis innovation. Greater regulatory convergence will help unlock cross-border research, harmonize quality standards and expand patient access globally. As global markets respond to this shift, rescheduling stands to accelerate the development, approval and international distribution of next-generation cannabis-based medicines. We welcome reforms that advance transparency, safety and patient access, and we look forward to contributing to a more connected, science-driven global cannabis ecosystem.
Betty Aldworth, co-executive director, MAPS; chair of the Marijuana Policy Project
The recently reported intent to reschedule cannabis by executive order marks a symbolic victory and a recalibration of decades of federal misclassification. If enacted, reclassifying cannabis as a Schedule III substance would be a long-overdue acknowledgment of its medical utility and a sharp rhetorical shift from Washington.
But symbolism is not structural reform. Rescheduling alone will not untangle the web of barriers facing cannabis consumers and the industry that serves them. It will not resolve the profound dangers of cash-only operations. It will not eliminate the risks to cannabis consumers embedded in housing policy, immigration policy, workplace drug testing, or family law. It will not establish the regulatory clarity required for millions of patients to receive insurance coverage when they choose cannabis over pharmaceutical interventions that may offer less benefit or carry greater risk.
This moment will generate headlines and optimism, but without comprehensive federal reform to address continued criminal sanctions, collateral consequences and financial obstructions faced by cannabis businesses, the communities most impacted by prohibition will continue to face disproportionate barriers.
Cannabis regulation is not a fringe experiment — it is a $38 billion economic engine operating under state-legal frameworks in nearly half of the country that has delivered overall positive social, educational, medical and economic benefits, including correlation with reductions in youth use in states where it’s legal. Cannabis policy must catch up to political reality. Anything less is not reform. It’s a delay.
Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.
This post appeared first on investingnews.com
(TheNewswire)
 |
|||||||||
Finders’ Fees consisting of $2,940 in cash commission and 21,000 non-transferable finders’ warrants were paid in connection with the Offering. Each finder’s warrant entitles the holder to acquire one common share at $0.20 cents per share over a 24-month period.
The net proceeds raised from the Offering will be used to advance the high-grade El Potrero gold-silver project in Durango, Mexico, for project evaluations, and for general working capital.
Insiders of the Company participated in the first tranche, subscribing for a total of 600,000 units and gross proceeds of $84,000. The participation of the insiders in the Offering will constitute a related-party transaction for the purposes of Multilateral Instrument 61-101 (Protection of Minority Security Holders in Special Transactions). The Company is exempt from the requirements to obtain a formal evaluation or minority shareholder approval in connection with the insider participation in reliance on sections 5.5(a) and 5.7(1)(a) of MI 61-101 as neither the fair market value of the securities issued, nor the fair market value of the consideration for the securities issued will exceed 25 per cent of the company’s market capitalization as calculated in accordance with MI 61-101.
All securities to be issued will be subject to a four-month hold period from the date of issuance and subject to TSX Venture Exchange approval. The securities offered have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements.
The Company expects to complete the second and final tranche of the Offering by January 30, 2026.
About the Potrero Property
El Potrero is located in the prolific Sierra Madre Occidental of western Mexico and lies within 35 kilometres of four operating mines, including the 4,000 tonnes per day (tpd) Ciénega Mine (Fresnillo), the 1,000 tpd Tahuehueto Mine (Luca Mining) and the 250 tpd Topia Mine (Guanajuato Silver).
High-grade gold-silver mineralization occurs in a low sulphidation epithermal breccia vein system hosted within andesites of the Lower Volcanic Series and has three historic mines along a 500 metre strike length. The property has been in private hands for almost 40 years and has never been systematically explored by modern methods, leaving significant exploration potential.
A previously operational 100 tpd plant on site can be refurbished / rebuilt and historic underground mine workings rehabilitated at relatively low cost in order to achieve near-term production once permits are in place. The property is road accessible with a power line within three kilometres.
Pinnacle will earn an initial 50% interest immediately upon commencing production. The goal would then be to generate sufficient cash flow with which to further develop the project and increase the Company’s ownership to 100% subject to a 2% NSR. If successful, this approach would be less dilutive for shareholders than relying on the equity markets to finance the growth of the Company.
About Pinnacle Silver and Gold Corp.
Pinnacle is focused on the development of precious metals projects in the Americas. The high-grade Potrero gold-silver project in Mexico’s Sierra Madre Belt hosts an underexplored low-sulphidation epithermal vein system and provides the potential for near-term production. In the prolific Red Lake District of northwestern Ontario, the Company owns a 100% interest in the past-producing, high-grade Argosy Gold Mine and the adjacent North Birch Project with an eight-kilometre-long target horizon. With a seasoned, highly successful management team and quality projects, Pinnacle Silver and Gold is committed to building long-term, sustainable value for shareholders.
Signed: ‘Robert A. Archer’
President & CEO
For further information contact:
Email: info@pinnaclesilverandgold.com
Tel.: +1 (877) 271-5886 ext. 110
Website: www.pinnaclesilverandgold.com
Neither the TSX Venture Exchange nor the Investment Industry Regulatory Organization of Canada accepts responsibility for the adequacy or accuracy of this release.
Copyright (c) 2025 TheNewswire – All rights reserved.
News Provided by TheNewsWire via QuoteMedia
This post appeared first on investingnews.com
LaFleur Minerals Inc. (CSE: LFLR,OTC:LFLRF) (FSE: 3WK0) (‘LaFleur Minerals’ or the ‘Company’ or ‘Issuer’) announces it has amended its previously disclosed non-brokered private placement offering, upsizing it to up to 9,000,000 units of the Company (the ‘Units’) at a price of $0.50 per Unit gross proceeds of up to $4,500,000 (the ‘LIFE Offering’). Each Unit will consist of one (1) common share in the capital of the Company (each a ‘Common Share’) and one (1) Common Share purchase warrant (a ‘Warrant’) granting the holder the right to purchase one (1) additional Common Share of the Company (a ‘Warrant Share’) at a price of $0.75 at any time on or before 36 months from the Closing Date (defined below). The Warrants will no longer be subject to an accelerated expiry, as was previously announced in the Company’s press release dated December 15, 2025.
The gross proceeds from the LIFE Offering will be used for the commissioning and restart of gold production operations at the Company’s wholly-owned Beacon Gold Mine and Mill, as well as work at the Company’s Swanson Gold Project in Quebec and for and general working capital purposes.
The Units will be offered for sale pursuant to the listed issuer financing exemption under Part 5A of National Instrument 45-106 – Prospectus Exemptions, as amended by CSA Coordinated Blanket Order 45-935 – Exemptions from Certain Conditions of the Listed Issuer Financing Exemption, to purchasers resident in Canada, excluding Quebec, and other qualifying jurisdictions.
The securities offered under the LIFE Offering will not be subject to a hold period in accordance with applicable Canadian securities laws. There is an offering document (the ‘Offering Document‘) related to the LIFE Offering that can be accessed under the Issuer’s profile at www.sedarplus.ca and at the Company’s website at www.lafleurminerals.com. Prospective investors should read this Offering Document before making an investment decision.
The terms of the Company’s previously announced flow-through offering (‘FT Offering’) have not changed, refer to the Company’s press release dated December 15, 2025 for more information.
The Company has agreed to pay qualified finders and brokers a cash commission of 7.0% of the aggregate gross proceeds of the LIFE Offering and FT Offering and such number of broker warrants (the ‘Broker Warrants‘) as is equal to 7.0% of the number of Units sold under the LIFE Offering and FT Offering. Each Broker Warrant will entitle the holder to purchase one Common Share at an exercise price equal to the Offering Price for a period of 24 months following the Closing Date.
The closing of the LIFE Offering and FT Offering is expected to occur on or about December 31, 2025 (the ‘Closing Date‘), or such other earlier or later date as the Company may determine.
The Company continues to progress in the closing of its previously announced brokered private placement of gold-linked convertible notes, as announced on November 5, 2025, a financing that aims to raise up to C$7 million to fund the restart of the company’s Beacon Gold Mill in Val d’Or, Quebec.
This news release is not an offer to sell or the solicitation of an offer to buy the securities in the United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The securities referred to in this news release have not been, nor will they be, registered under the United States Securities Act of 1933, as amended (the ‘U.S. Securities Act’), and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent an exemption from registration under the U.S. Securities Act and applicable U.S. state securities laws. ‘United States’ and ‘U.S. person’ are as defined in Regulation S under the U.S Securities Act.
About LaFleur Minerals Inc.
LaFleur Minerals Inc. (CSE: LFLR,OTC:LFLRF) (FSE: 3WK0) is focused on the development of district-scale gold projects in the Abitibi Gold Belt near Val-d’Or, Québec. Our mission is to advance mining projects with a laser focus on our resource-stage Swanson Gold Deposit and the Beacon Gold Mill, which have significant potential to deliver long-term value. The Swanson Gold Project is approximately 18,304 hectares (183 km2) in size and includes several prospects rich in gold and critical metals previously held by Monarch Mining, Abcourt Mines, and Globex Mining. LaFleur has recently consolidated a large land package along a major structural break that hosts the Swanson, Bartec, and Jolin gold deposits and several other showings which make up the Swanson Gold Project. The Swanson Gold Project is easily accessible by road allowing direct access to several nearby gold mills, further enhancing its development potential. Lafleur Mineral’s fully refurbished and permitted Beacon Gold Mill is capable of processing over 750 tonnes per day and is being considered for processing mineralized material at Swanson and for custom milling operations for other nearby gold projects.
ON BEHALF OF LaFleur Minerals INC.
Paul Ténière, M.Sc., P.Geo.
Chief Executive Officer
E: info@lafleurminerals.com
LaFleur Minerals Inc.
1500-1055 West Georgia Street
Vancouver, BC V6E 4N7
Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this news release.
Cautionary Statement Regarding ‘Forward-Looking’ Information
This news release includes certain statements that may be deemed ‘forward-looking statements’. All statements in this new release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words ‘expects’, ‘plans’, ‘anticipates’, ‘believes’, ‘intends’, ‘estimates’, ‘projects’, ‘potential’ and similar expressions, or that events or conditions ‘will’, ‘would’, ‘may’, ‘could’ or ‘should’ occur. Forward-looking statements in this news release include, without limitation, statements related to the closing of the LIFE Offering and the FT Offering, and the anticipated use of proceeds from the LIFE Offering and the FT Offering. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward-looking statements. Factors that could cause the actual results to differ materially from those in forward-looking statements include market prices, continued availability of capital and financing, and general economic, market or business conditions. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. Forward-looking statements are based on the beliefs, estimates and opinions of the Company’s management on the date the statements are made. Except as required by applicable securities laws, the Company undertakes no obligation to update these forward-looking statements in the event that management’s beliefs, estimates or opinions, or other factors, should change.
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/278557
News Provided by Newsfile via QuoteMedia
This post appeared first on investingnews.com
China denounced the United States for approving an $11.1 billion weapons package for Taiwan, warning that the deal risks turning the island into a ‘powder keg’ and driving the region toward ‘military confrontation and war.’
The unprecedented sale includes 82 HIMARS launchers paired with 420 ATACMS long-range missiles, a combination that would give Taiwan new deep-strike capability across the Taiwan Strait, along with 60 self-propelled howitzers, advanced UAV systems, military software packages and anti-armor weapons.
Beijing accused Taiwan’s leadership of ‘seeking independence through force’ and claimed Washington is using the island to ‘contain China,’ rhetoric that signals heightened tensions even as the U.S. frames the package as essential to bolstering Taiwan’s self-defense.
‘The ‘Taiwan independence’ forces on the island seek independence through force and resist reunification through force, squandering the hard-earned money of the people to purchase weapons at the cost of turning Taiwan into a powder keg,’ Foreign Ministry spokesperson Guo Jiakun said.
‘This cannot save the doomed fate of ‘Taiwan independence’ but will only accelerate the push of the Taiwan Strait toward a dangerous situation of military confrontation and war. The U.S. support for ‘Taiwan Independence’ through arms will only end up backfiring. Using Taiwan to contain China will not succeed.’
U.S. officials have not yet detailed delivery timelines, but the sale reflects Washington’s push to accelerate Taiwan’s defenses amid growing concern over China’s military pressure campaign. The HIMARS and ATACMS combination is expected to draw particular attention from Beijing because it would allow Taiwan to target PLA staging areas, ships and infrastructure from mobile launchers, a capability China has repeatedly warned against.
In its notification to Congress, the State Department said the proposed sales would advance ‘U.S. national, economic, and security interests by supporting the recipient’s continuing efforts to modernize its armed forces and to maintain a credible defensive capability.’
The department added that the weapons would ‘help improve the security of the recipient and assist in maintaining political stability, military balance and economic progress in the region.’
Under longstanding U.S. policy, Washington provides Taiwan with arms it deems necessary for the island’s self-defense while maintaining a ‘One China’ policy and not supporting a declaration of formal independence. China argues that any enhancement of Taiwan’s defenses encourages separatism, while U.S. officials say the purpose of such sales is to preserve stability and deter conflict.
The package now enters a 30-day congressional review period, during which lawmakers could file a resolution attempting to block it, a step Congress has never taken for an arms sale to Taiwan. Once the review period ends, contracting and production begin, a process that typically stretches over several years and contributes to a backlog that once reached $20 billion in undelivered U.S. weapons Taiwan has already purchased.
China has a track record of responding to major Taiwan arms sales with military demonstrations, including large-scale PLA drills, increased air and naval activity near the island and sanctions on U.S. defense firms. Analysts say Beijing’s sharp rhetoric suggests additional military signaling is likely, though China did not immediately announce specific countermeasures.
The latest sale marks a significant boost to Taiwan’s conventional firepower. In recent months, Beijing has stepped up pressure across the strait with near-daily PLA air and naval patrols, record incursions around the island and high-profile exercises meant to signal its ability to encircle Taiwan.
Taiwan’s Foreign Minister Lin Chia-lung thanked the U.S. Wednesday for its ‘long-term support for regional security and Taiwan’s self-defense capabilities,’ which he said are key to deterring a conflict in the Taiwan Strait.
This post appeared first on FOX NEWS
In a Thursday press conference, federal authorities in Minnesota announced new charges in the fraud scandal that has grabbed national headlines and spoke on the scope of the crisis, saying that it goes beyond what has previously been reported.
‘Minnesotans and taxpayers deserve to know the truth of the fraud,’ First Assistant U.S. Attorney Joe Thompson told reporters at a press conference. ‘The fraud is not small. It isn’t isolated. The magnitude cannot be overstated. What we see in Minnesota is not a handful of bad actors committing crimes. It’s staggering industrial-scale fraud. It’s swamping Minnesota and calling into question everything we know about our state.’
Thompson explained that 14 programs have been identified as containing fraud and those programs have cost taxpayers $18 billion overall since 2018.
When asked specifically by a reporter how much of that $18 billion is suspected to be fraudulent, which reports have previously suggested could be around $1 billion, Thompson suggested that number will be higher when the investigations are concluded.
‘I think a significant portion,’ Thompson responded.
Thompson later said, ‘When I say significant, I’m talking in the order of half or more. But we’ll see.’
Six new defendants have been charged in connection with a Minnesota housing services fraud, Thompson revealed on Thursday.
Two defendants pocketed $750,000 instead of helping Medicaid recipients find stable housing, Thompson said. Prosecutors allege they used the proceeds to travel to international destinations, including London, Istanbul and Dubai.
One defendant submitted $1.4 million in fraudulent claims, using some to purchase cryptocurrency, Thompson said. Federal officials say he fled the country after receiving a subpoena.
The six new defendants join eight others charged in September for their alleged roles in the scheme to defraud the Minnesota Housing Stability Services Program.
Two dependents mentioned by Thompson sent significant sums of money overseas to Kenya, in one case over $200,000.
‘There’s been a significant amount of money sent abroad, mostly to East Africa, much of it to Kenya and to Nairobi, that the money that we’ve traced most, most of which has been used to purchase real estate in Nairobi,’ Thompson said, mentioning the ‘large Somali diaspora’ in those areas.
Prosecutors also named a new defendant accused of defrauding another state-run, federally funded program that provides services for children with autism, alleging he submitted millions of dollars worth of claims for Medicaid reimbursement. One woman previously charged with exploiting that program pleaded guilty Thursday morning, officials said.
Thompson said that two of the dependents aren’t from Minnesota but came from Philadelphia because ‘they heard that Minnesota and its housing stabilization services program was easy money.’
‘What we’re seeing is programs that are just entirely fraudulent,’ Thompson said. ‘These aren’t companies that are providing some services, but overbilling Medicare, Medicaid. These are companies that are providing essentially no services. They’re essentially shell companies created to defraud the program created to submit on a wholesale level, fraudulent claims for services that aren’t necessary and are provided.’
In a press release, dependents were identified as Abdinajib Hassan Yussuf, Anthony Waddell Jefferson, Lester Brown, Hassan Ahmed Hussein, Ahmed Abdirashid Mohamed, and Kaamil Omar Sallah.
Minnesota’s fraud crisis has been in the spotlight in recent weeks as the Trump administration and local Republicans have blasted Minnesota’s elected officials over the scandal, which dates back to at least 2020 and involves fraudulent billing for a wide range of government services, mostly involving, but not limited to, the state’s Somali community.
‘When I was on the Feeding Our Future case, the big thing that jumped out to me was, honestly, how easy this fraud was to do,’ former federal prosecutor Joe Teirab, who worked on the fraud investigation into Feeding our Future, one of the most high-profile examples of organizations that prosecutors say was propped up by fraud, recently told Fox News Digital.
‘I mean, these fraudsters were just saying that they were spending all this money on feeding kids, and they were just making up these PDFs, putting false names into Excel sheets. I could do that in five minutes on a computer if I had absolutely no conscience.’
The Trump administration has launched a variety of efforts to crack down and investigate the fraud at a federal level and Fox News Digital first reported that Education Secretary Linda McMahon had sent a letter to Walz calling on him to resign over the scandal.
‘It’s been allowed to go on for far too long, and we need to do whatever we can to stop it in its tracks,’ Thompson said in the press conference.
Associated Press contributed to this report.
This post appeared first on FOX NEWS